Frontiers | A Prognostic Model for Glioblastoma Patients Treated With Standard Therapy Based on a Prospective Cohort of Consecutive Non-Selected Patients From a Single Institution
Longer-term (≥ 2 years) survival in patients with glioblastoma in population-based studies pre- and post-2005: a systematic review and meta-analysis | Scientific Reports
National cancer database analysis of outcomes in pediatric glioblastoma - Liu - 2018 - Cancer Medicine - Wiley Online Library
JCI - Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme
Frontiers | Valproic Acid Enhanced Temozolomide-Induced Anticancer Activity in Human Glioma Through the p53–PUMA Apoptosis Pathway
Overall survival and progression-free survival among 28 glioblastoma... | Download Scientific Diagram
Cureus | Rising Incidence of Glioblastoma Multiforme in a Well-Defined Population | Article
Frontiers | Epidemiologic Features, Survival, and Prognostic Factors Among Patients With Different Histologic Variants of Glioblastoma: Analysis of a Nationwide Database
Prognostic Factors and Survival of Glioblastoma Multiform (GBM) in Iranian Patients | International Journal of Cancer Management | Full Text
Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway | BMJ Open
Glioblastoma Multiforme in the over 70's: “To treat or not to treat with radiotherapy?” - Glynn - 2019 - Cancer Medicine - Wiley Online Library
Current Oncology | Free Full-Text | Outcomes in Elderly Patients with Glioblastoma Multiforme Treated with Short-Course Radiation Alone Compared to Short-Course Radiation and Concurrent and Adjuvant Temozolomide Based on Performance Status and
Cureus | Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme | Article